Callisto Pharmaceuticals is a Biotechnology company that develops novel therapeutics to treat gastrointestinal diseases and cancer. We source our drug candidates from breakthrough science, both internal and external. Located in Manhattan, New York, NY, we are listed on the American Stock Exchange under the symbol KAL and on the Frankfurt Exchange under the symbol CA4.
Focus on Guanilib
Listen to our Webcast about Guanilib
Read More
Investor Presentation
View our ASCO 2008 poster for Atiprimod
Read More
Latest News
See our latest press releases
Read More